Ohcanbohtosat - P. D. Badman

Results of the phase IIa RADICAL trial of the FGFR inhibitor AZD4547 in endocrine resistant breast cancer Dahkki R. Charles Coombes, P. D. Badman, Jingky Lozano-Kühne, X. Liu, Iain R. Macpherson, Ishtiaq Husain Zubairi, Richard D. Baird, Nitzan Rosenfeld, Javier Garciá Corbacho, Nicola Cresti, Ruth Plummer, Andrew J. Armstrong, R. Allerton, Dónal Landers, H. Nicholas, L. McLellan, Andrew Kean Seng Lim, Florent Moulière, Olivier E. Pardo, Veronica Ferguson, Michael J. Seckl